Cholesterol guidelines will triple numbers taking drugsBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7297.1270/a (Published 26 May 2001) Cite this as: BMJ 2001;322:1270
- Deborah Josefson
- San Francisco
The US National Institutes of Health, through its national cholesterol education programme, has issued sweeping new clinical practice and management guidelines designed to lower cholesterol levels.
The guidelines call for more aggressive diagnosis and treatment of hypercholesterolaemia and for a change from the acceptable, healthy level of high density lipoprotein (HDL) from a minimum of 35 mg/dl (0.91 mmol/l) to 40 mg/dl (1.03 mmol/l). They also endorse the wider use of lipid lowering drugs and lifestyle changes.
The new guidelines will substantially increase the number of Americans considered to be at risk of heart disease and expand the number who will receive dietary and drug treatment. The number of Americans who …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial